Glycopeptide-based solutions for industrial and environmental applications
Legal Citation
Summary of the Inventive Concept
This inventive concept leverages the core technology of lipo-glycopeptide cleavable derivatives to develop innovative solutions for industrial and environmental challenges, including agricultural pest control, crop protection, biofilm prevention, marine vessel biofouling, and industrial wastewater treatment.
Background and Problem Solved
The original patent focused on treating Gram-positive bacterial infections, but the limitations of this approach include the lack of consideration for other industries and applications. This inventive concept addresses the need for effective solutions in industrial and environmental sectors, where the unique properties of lipo-glycopeptide cleavable derivatives can provide significant benefits.
Detailed Description of the Inventive Concept
The new claims describe various systems, methods, and devices that utilize glycopeptide-based compositions to tackle specific industrial and environmental challenges. For instance, the glycopeptide-based bait in claim 1 attracts and controls agricultural pests, while the composition in claim 2 inhibits fungal growth and promotes plant health. Similarly, the glycopeptide-based coatings in claims 3 and 4 detect and disrupt biofilm formation, reducing equipment downtime and maintenance costs, and prevent biofouling of marine vessels, improving fuel efficiency and reducing emissions. Finally, the composition in claim 5 degrades organic pollutants and promotes water purification in industrial wastewater treatment.
Novelty and Inventive Step
The new claims introduce a significant inventive step by applying the core technology to entirely new industries and applications, including agriculture, environmental protection, and industrial processes. This departure from the original patent's focus on Gram-positive bacterial infections demonstrates the novelty and non-obviousness of the inventive concept.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different glycopeptide structures, varying lipophilic moieties, or alternative delivery mechanisms. Additionally, the concept could be adapted for use in other industries, such as oil and gas, or in combination with other technologies, like nanotechnology or biotechnology.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in various industries, including agriculture, environmental protection, industrial processes, and marine transportation. The market for these solutions is substantial, with potential customers including agricultural companies, industrial equipment manufacturers, marine vessel operators, and wastewater treatment facilities.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K38/14 |
| A | A61 | A61K9/008 |
| A | A61 | A61K9/0073 |
| A | A61 | A61K9/0075 |
| A | A61 | A61P31/04 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biotechnology and pharmaceutical chemistry, with expertise in glycopeptide derivatives, drug delivery systems, and antimicrobial applications
Person of Ordinary Skill (PHOSITA) Profile
A researcher with advanced degrees in chemistry or biochemistry, familiar with molecular modification techniques, drug delivery mechanisms, and cross-industry applications of bioactive compounds
Obviousness Rationale
A person skilled in the art would recognize the fundamental structural similarities between the source patent's lipo-glycopeptide derivatives and the PTD's proposed applications. The core chemical structure and enzymatic cleavage mechanism provide a predictable platform for exploring alternative industrial and environmental uses. The PTD represents a straightforward extension of known glycopeptide technology into new problem domains using standard molecular engineering approaches.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,597 |
|---|---|
| Title | Lipo-glycopeptide cleavable derivatives and uses thereof |
| Assignee(s) | Insmed Incorporated |